Donald Burkindine
Geriatric Medicine · Marshfield, MONPI 1245235498
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 6 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 4 manufacturers reported payments, led by AbbVie at 34.5% of the total. Reporting peaked in 2019 at $54 and has fallen 66.1% since, to $18 in 2021. That places this record below the midpoint for geriatric medicine clinicians in MO, where the typical reported total is $256.
Across 6 payments — averaging $14.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$29
- AstraZeneca$24
- Radius Health, Inc.$18
- Takeda Pharmaceuticals U.S.A., Inc.$14
Across 70 payments — averaging $165,678 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$5.7M
- Boehringer Ingelheim International GmbH$2.7M
- AbbVie$1.7M
- Vanda Pharmaceuticals Inc.$791K
- Bayer$427K
- Coherus Oncology, Inc.$287K
- plus $19K from 2 others
What the payments were for
- Food & beverage$85100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 2 | $29 |
| AstraZeneca | 2 | $24 |
| Radius Health, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$85 in reported general payments places this provider in the 35th percentile of 76 geriatric medicine providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 22 | $7,872 |
| LinzessLinaclotide | 12 | $6,898 |
| Trospium Chloride | 22 | $925 |
| Baclofen | 22 | $601 |
| Haloperidol | 23 | $587 |
| Atorvastatin Calcium | 67 | $492 |
| Bupropion XlBupropion Hcl | 23 | $411 |
| Levothyroxine Sodium | 27 | $274 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 22 | $236 |
| Topiramate | 23 | $231 |
| Montelukast Sodium | 22 | $201 |
| Escitalopram Oxalate | 17 | $146 |
| Lisinopril | 22 | $102 |
| Alendronate Sodium | 12 | $95 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLinzess | $29 | $6,89812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 76 geriatric medicine providers in Missouri.
Other geriatric medicine in Marshfield
- Srinath TadakamallaHarrisonville$82K
- Randall HalleyColumbia$18K
- Angela SanfordSaint Louis$15K
- Madhu SahaiSikeston$6K
- John MorleySt Louis$6K
- Karmel CarothersIndependence$5K
- William KnappFlorissant$5K
- Ellen BinderSaint Louis$4K
- Poonam JainSaint Louis$4K
- Uchenna OgbuokiriSaint Louis$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.